InMode stock analysis
InMode (154) Stock Price & Analysis
154 Stock Chart & Stats
- Day’s Range
- EUR 11.75 - EUR 11.75
- 52-Week Range
- EUR 11.02 - EUR 13.88
- Previous Close
- EUR 11.85
- Volume
- N/A
- Average Volume (3M)
- 8
- Market Cap
- EUR 676.22M
- Enterprise Value
- EUR 316.22M
- Total Cash (Recent Filing)
- EUR 512.73M
- Total Debt (Recent Filing)
- EUR 3.58M
- Price to Earnings (P/E)
- 10.5
- Beta
- 0.41
- Next Earnings
- Feb 10, 2027 (Est.)
- EPS Estimate
- 0.32
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Extremely low leverage gives InMode substantial financial flexibility to fund product development, sales expansion, and shareholder returns without relying heavily on borrowing. The large equity base also improves resilience if demand remains uneven or profitability takes longer to recover.
Strong Profitability And Cash Conversion
High gross margins indicate that InMode’s technology-led device model retains meaningful economics after direct costs. Close free-cash-flow conversion of earnings further supports internally funded operations, although the recent direction of cash generation has weakened.
Product And Geographic Expansion
A record quarter in Asia alongside a successful Morpheus8 Max launch provides evidence of ongoing commercial expansion beyond the existing product base. New platform adoption can support future system placements and recurring procedure-related revenue from the installed base.
Bears Say
Sustained Revenue Decline
Repeated revenue contraction signals that weaker demand or slower system sales is not limited to a single quarter. Continued top-line pressure can reduce operating leverage, constrain investment capacity, and make a durable return to prior growth rates more difficult.
Margin And Cash-flow Deterioration
Although profitability remains positive, declining margins and negative free-cash-flow growth show that earnings quality is moving in the wrong direction. If this persists, InMode may generate less cash per dollar of revenue and have less capacity to sustain growth initiatives.
Weakening Recurring Revenue
Consumables and services are important repeat-revenue streams tied to utilization of InMode’s installed systems. Their decline suggests softer procedure activity or utilization and could weaken the recurring foundation that normally complements one-time capital-equipment sales.
InMode News
154 FAQ
What was InMode’s price range in the past 12 months?
What is InMode’s market cap?
When is InMode’s upcoming earnings report date?
How were InMode’s earnings last quarter?
Is InMode overvalued?
Does InMode pay dividends?
What is InMode’s EPS estimate?
How many shares outstanding does InMode have?
What happened to InMode’s price movement after its last earnings report?
Which hedge fund is a major shareholder of InMode?
What is the TipRanks Smart Score and how is it calculated?
InMode Stock Smart Score
Company Description
InMode
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Moshe Mizrahy
- Employees
- 660
- Website
- www.inmodemd.com
- Address
- Tavor Building, Yokne'am, TA, 2069206, IL
InMode (154) Earnings & Revenues
154 Earnings Call
Earnings Call SentimentNeutral
The call contained a mix of modest top-line progress and strategic positives (5% revenue growth, strong cash balance, product launches, sales reorganization and share repurchases) offset by notable margin compression, rising operating expenses and declines in EPS. Management provided steady full-year guidance and described early signs of stabilization in the U.S., but profitability pressures and macroeconomic headwinds temper the outlook. International and product development initiatives offer upside, while near-term margin and demand uncertainty are the primary negatives.
View all DE:154 earnings summaries154 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |











